VivoPower
VIVONASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $2.00 Prior regular-session close from the quote source.
- $1.91–$2.34 Regular-session low and high so far today.
- 961.2K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $1.20–$6.86 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own VIVO if VivoPower is not yet an operating compounder; it is a high-risk recapitalization option whose value depends on funding, balance-sheet repair, and proving that customers will buy again at positive contribution margins.
VIVO price history
Loading recent earnings…
Investment thesis
What must happen next
Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value.StrengtheningMateriality: High
IFRS FY2025 year-end cash was $60,000. If funding arrives on tolerable terms, shareholders retain option value; if it does not, creditors or new capital can capture the upside before operations recover.
Watch: A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
IFRS FY2025 year-end cash was $60,000.
Open source ↗The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base.StrengtheningMateriality: High
IFRS annual revenue fell from $10.160 million in FY2022 to $4.055 million in FY2023, then to $16,000 in FY2024. A real order book would make the company financeable and give operating leverage a chance; absent that, new capital only funds burn.
Watch: VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
IFRS annual revenue fell from $10.160 million in FY2022 to $4.055 million in FY2023, then to $16,000 in FY2024.
Open source ↗VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive.HoldingMateriality: Medium
IFRS FY2025 annual gross_profit was positive $11,000 on $61,000 of revenue. Positive unit economics would allow scale to matter; negative gross profit would mean every new dollar of sales consumes more capital.
Watch: New contracts require below-cost pricing to win work from incumbent providers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
IFRS FY2025 annual gross_profit was positive $11,000 on $61,000 of revenue.
Open source ↗The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders.StrengtheningMateriality: Medium
IFRS FY2025 annual operating_income was negative $8.723 million on $61,000 of revenue. If overhead remains disconnected from revenue, even better gross margins will not stop cash burn; if fixed costs reset, smaller revenue can create a path to break-even.
Watch: Management completes disclosed overhead reductions, divestitures, or outsourcing that structurally lower the cash cost base.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
IFRS FY2025 annual operating_income was negative $8.723 million on $61,000 of revenue.
Open source ↗Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits.StrengtheningMateriality: Medium
IFRS FY2025 year-end liabilities were $77.024 million. A creditor-friendly restructuring can leave the business alive but existing shareholders diluted or impaired; a clean liability settlement preserves the option on recovery.
Watch: Major liabilities are converted, extended, or settled without punitive dilution to common shareholders.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
IFRS FY2025 year-end liabilities were $77.024 million.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value. If funding arrives on tolerable terms, shareholders retain option value; if it does not, creditors or new capital can capture the upside before operations recover.
The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base. A real order book would make the company financeable and give operating leverage a chance; absent that, new capital only funds burn.
VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive. Positive unit economics would allow scale to matter; negative gross profit would mean every new dollar of sales consumes more capital.
The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders. If overhead remains disconnected from revenue, even better gross margins will not stop cash burn; if fixed costs reset, smaller revenue can create a path to break-even.
Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits. A creditor-friendly restructuring can leave the business alive but existing shareholders diluted or impaired; a clean liability settlement preserves the option on recovery.
All standing thesis claims
Original report summary
VivoPower is not yet an operating compounder; it is a high-risk recapitalization option whose value depends on funding, balance-sheet repair, and proving that customers will buy again at positive contribution margins.
Bull case and bear case
Bull case and bear case for VivoPower
Where the evidence on VivoPower stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.
Bull case: what the evidence supports
Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value.
The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base.
VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive.
The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders.
Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits.
Bear case: what would count against it
A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.
VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.
New contracts require below-cost pricing to win work from incumbent providers.
Thesis-Break Engine
Thesis-break watch · VivoPower
No break has crossed VivoPower’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
VivoPower filed an SEC report on 2026-08-28: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
VivoPower filed an SEC report on 2026-08-21: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
VivoPower filed an SEC report on 2026-08-03: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.
- VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.
- New contracts require below-cost pricing to win work from incumbent providers.
- Management completes disclosed overhead reductions, divestitures, or outsourcing that structurally lower the cash cost base.
- Major liabilities are converted, extended, or settled without punitive dilution to common shareholders.
VIVO news
Loading headlines…
Financial statements
VIVO income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
VIVO: quick answers
- What is VIVO's short interest?
- As of October 30, 2026, 2.0M VIVO shares were sold short, down 4.6% from the count before. At the stock's average daily volume that is 1.5 days to cover. FINRA publishes the count twice a month. VIVO short interest history
- Have members of Congress traded VIVO?
- 5 trades in VIVO have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed VIVO trade
